Lupus & antiphospholipid syndrome
Prevalence of pulmonary diseases among patients newly diagnosed with systemic lupus erythematosus: A cross-sectional case-series introducing thoracic ultrasound and diaphragmatic ultrasound
Authors' conclusion
We found PD among newly diagnosed patients with SLE and in some cases associated with severely affected pulmonary function.
Study context
- Population
- Patients newly diagnosed with Systemic Lupus Erythematosus (SLE), 1 July 2023 to 31 July 2024, Odense University Hospital, Denmarkincluded avg 3 months after SLE diagnosis
- Participants
- 10 patients
- Outcome
- Presence of pulmonary diseases (PD) and PD subtypes, diagnosed on multidisciplinary discussion
Methodological detailscase series, single-centre
- Case series
- Single-centre
Main finding
As reported in the abstract
Pulmonary diseases (PD)
Participants with PD
6 of 10
Shrinking lung syndrome (SLS)
1
ILD
2
Observational data: associations, not effects.
Further findings
Pulmonary function tests (PFT)
- Participants with ≥1 abnormal PFT measure
- 10 of 10
- Some with severely reduced pulmonary function
Thoracic US (thoracic ultrasound (TUS)) and diaphragmatic US (diaphragmatic ultrasound (DUS))
- TUS associated with diseases of lung parenchyma and pleura; DUS with SLS
Original publication
Prevalence of pulmonary diseases among patients newly diagnosed with systemic lupus erythematosus: A cross-sectional case-series introducing thoracic ultrasound and diaphragmatic ultrasound. Lupus. Published 7 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →